Next Article in Journal
The Octopus Sign—A New HRCT Sign in Pulmonary Langerhans Cell Histiocytosis
Previous Article in Journal
Radiomics Analysis of Brain [18F]FDG PET/CT to Predict Alzheimer’s Disease in Patients with Amyloid PET Positivity: A Preliminary Report on the Application of SPM Cortical Segmentation, Pyradiomics and Machine-Learning Analysis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Interesting Images

Unusual Focal Lung Uptake without CT Abnormality on a Bone Scan: What Might It Mean?

1
Nuclear Medicine Department, Institut Régional du Cancer de Montpellier (ICM), University Montpellier, 34298 Montpellier, France
2
IBMM, University of Montpellier, CNRS, ENSCM, 34293 Montpellier, France
3
Medical Oncology Departement, Institut Régional du Cancer de Montpellier (ICM), University Montpellier, 34298 Montpellier, France
4
Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, Institut Régional du Cancer de Montpellier (ICM), University Montpellier, 34298 Montpellier, France
*
Author to whom correspondence should be addressed.
Diagnostics 2022, 12(4), 934; https://doi.org/10.3390/diagnostics12040934
Submission received: 17 March 2022 / Revised: 5 April 2022 / Accepted: 7 April 2022 / Published: 8 April 2022
(This article belongs to the Topic Diagnostic Imaging and Pathology in Cancer Research)

Abstract

:
A 48-year-old woman was referred for a bone scan as an assessment of bone metastasis from breast cancer. Surprisingly, two hot spots of lung uptake were present in the left lung without any abnormality on CT slices. No history of pulmonary disease was observed. An optimized CT scan with fine slices performed the same day was strictly normal (without any micronodule). A lung ventilation/perfusion scintigraphy showed no significant perfusion defect. A follow-up bone scan performed eight months later was normal and without any lung uptake. After exclusion of the main etiologies described in the literature, such as amylosis, sarcoidosis, abscess, or hypercalcemia, radiotracer microembolism seems to be the most likely hypothesis in this patient.

Figure 1. Whole body bone scan: posterior view (A), anterior view (B), axial SPECT-CT fused slices (C,D), correspondent CT slices (E,F). A 48-year-old woman was referred for a bone scan for assessment of bone metastasis from breast cancer. Posterior whole-body scan performed 2 h 30 min after IV injection of 825 MBq of 99mTc-hydroxymethylene diphosphonate (99mTc-HDP) highlighted two extra-osseous foci in projection of the 8th left rib (Figure 1A). Axial SPECT-CT fused slices showed an intense focal uptake in the left posterobasal lung segment close to proximal inferior lobe vessel (Figure 1C) and a less intense and more distal second focal uptake in the left anterobasal segment (Figure 1D). No abnormality was visible on correspondent CT slices (Figure 1E,F). Bone metastasis were limited to sternal body and left femoral diaphysis with mild osteoblastic activity. The patient had predominant liver metastasis, and carried out a combined treatment with trastuzumab, pertuzumab, letrozole, denosumab, calcium carbonate, and vitamin D3. The patient performed a contrast CT scan on the same day, thus, iobitridol was injected between 99mTc-HDP intravenous injection and bone scan images acquisition. Fine helical slices showed no abnormality and especially no nodule or micronodule in the left lung. In order not to miss out a pulmonary embolism, ventilation/perfusion scintigraphy was performed five days later (Figure 2A,B), showing no significant perfusion defect. Eight months later, the follow-up bone scan showed no lung abnormality (Figure 2C,D), suggesting a non-pathological condition.
Figure 1. Whole body bone scan: posterior view (A), anterior view (B), axial SPECT-CT fused slices (C,D), correspondent CT slices (E,F). A 48-year-old woman was referred for a bone scan for assessment of bone metastasis from breast cancer. Posterior whole-body scan performed 2 h 30 min after IV injection of 825 MBq of 99mTc-hydroxymethylene diphosphonate (99mTc-HDP) highlighted two extra-osseous foci in projection of the 8th left rib (Figure 1A). Axial SPECT-CT fused slices showed an intense focal uptake in the left posterobasal lung segment close to proximal inferior lobe vessel (Figure 1C) and a less intense and more distal second focal uptake in the left anterobasal segment (Figure 1D). No abnormality was visible on correspondent CT slices (Figure 1E,F). Bone metastasis were limited to sternal body and left femoral diaphysis with mild osteoblastic activity. The patient had predominant liver metastasis, and carried out a combined treatment with trastuzumab, pertuzumab, letrozole, denosumab, calcium carbonate, and vitamin D3. The patient performed a contrast CT scan on the same day, thus, iobitridol was injected between 99mTc-HDP intravenous injection and bone scan images acquisition. Fine helical slices showed no abnormality and especially no nodule or micronodule in the left lung. In order not to miss out a pulmonary embolism, ventilation/perfusion scintigraphy was performed five days later (Figure 2A,B), showing no significant perfusion defect. Eight months later, the follow-up bone scan showed no lung abnormality (Figure 2C,D), suggesting a non-pathological condition.
Diagnostics 12 00934 g001
Figure 2. Subsequent scintigraphic investigations with ventilation/perfusion scintigraphy: ventilation axial SPECT slices (A), perfusion axial SPECT slices (B); and follow-up whole body bone scan: posterior view (C), anterior view (D). Extraosseous uptake on bone scan with 99mTc-HDP or 99mTc-methylene diphosphonate (99mTc-MDP) have been well described, with great improved diagnosis accuracy in the era of SPECT/CT [1,2,3]. In particular, focal lung uptake can be due to several causes such as sarcoidosis, amylosis, lung metastasis, lung abscess, or hypercalcemia [4,5,6]. None of these conditions was present in our patient. Furthermore, unusual lung focal uptake with no morphological abnormality on CT scan were described with several radiotracers such as 99mTc-dimercaptosuccinic acid (99mTc-DMSA) [7], 99mTc-sestamibi [8,9], 68Ga-DOTANOC [10], more recently 68Ga-PSMA-11 [11] and above all 18F-fluorodesoxiglucose (18FDG) with which lung hot spots could be present in up to 1.5/1000 exams [12,13]. Despite the great number of bone scan practiced worldwide since decades, this pattern seems extremely rare with bone-seeking tracers, described once with 99mTc-MDP [14]. A paravenous radiotracer injection due to extravasation has been incriminated in a few cases [15]. Indeed, this was objectified in our patient (slight focal uptake near right elbow on anterior whole-body scan (Figure 1B, white arrow)). When performed, a new scintigraphy showing a normal pattern suggests that this cannot be due to pathological condition [12]. The conformity of the radiopharmaceutical preparation was not questionable (radiochemical purity > 97% and pH = 6, as recommended by the summary of products characteristics of the HDP cold kit). Although the patient dose was prepared 30 min before injection, neither instability nor significant interaction with the syringe were reported in the literature [16]. Furthermore, seven other patient syringes were prepared this day from the same multidose vial of 99mTc-HDP and provided bone scans without such abnormality. In view of the clinic, and since the other causes already described seem to be excluded, the main causal hypothesis remains iatrogenic lung microemboli of the tracer, developed secondary to agglutination of 99mTc-HDP with clotting elements that led to transient obstruction in tiny pulmonary arterioles.
Figure 2. Subsequent scintigraphic investigations with ventilation/perfusion scintigraphy: ventilation axial SPECT slices (A), perfusion axial SPECT slices (B); and follow-up whole body bone scan: posterior view (C), anterior view (D). Extraosseous uptake on bone scan with 99mTc-HDP or 99mTc-methylene diphosphonate (99mTc-MDP) have been well described, with great improved diagnosis accuracy in the era of SPECT/CT [1,2,3]. In particular, focal lung uptake can be due to several causes such as sarcoidosis, amylosis, lung metastasis, lung abscess, or hypercalcemia [4,5,6]. None of these conditions was present in our patient. Furthermore, unusual lung focal uptake with no morphological abnormality on CT scan were described with several radiotracers such as 99mTc-dimercaptosuccinic acid (99mTc-DMSA) [7], 99mTc-sestamibi [8,9], 68Ga-DOTANOC [10], more recently 68Ga-PSMA-11 [11] and above all 18F-fluorodesoxiglucose (18FDG) with which lung hot spots could be present in up to 1.5/1000 exams [12,13]. Despite the great number of bone scan practiced worldwide since decades, this pattern seems extremely rare with bone-seeking tracers, described once with 99mTc-MDP [14]. A paravenous radiotracer injection due to extravasation has been incriminated in a few cases [15]. Indeed, this was objectified in our patient (slight focal uptake near right elbow on anterior whole-body scan (Figure 1B, white arrow)). When performed, a new scintigraphy showing a normal pattern suggests that this cannot be due to pathological condition [12]. The conformity of the radiopharmaceutical preparation was not questionable (radiochemical purity > 97% and pH = 6, as recommended by the summary of products characteristics of the HDP cold kit). Although the patient dose was prepared 30 min before injection, neither instability nor significant interaction with the syringe were reported in the literature [16]. Furthermore, seven other patient syringes were prepared this day from the same multidose vial of 99mTc-HDP and provided bone scans without such abnormality. In view of the clinic, and since the other causes already described seem to be excluded, the main causal hypothesis remains iatrogenic lung microemboli of the tracer, developed secondary to agglutination of 99mTc-HDP with clotting elements that led to transient obstruction in tiny pulmonary arterioles.
Diagnostics 12 00934 g002

Author Contributions

Conceptualization, M.-C.E. and C.F.; validation, S.G. (Sophie Guillemard) and D.I.; investigation, M.-C.E. and C.F.; writing—original draft preparation, M.-C.E.; writing—review and editing, C.F. and E.D.; visualization, S.G. (Séverine Guiu), S.G. (Sophie Guillemard) and D.I.; supervision, E.D. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Ethical review and approval were waived for this work because it contains a presentation of the description of diagnostic tests of a selected patient; the work does not describe a medical experiment—the opinion of the bioethics committee was not required.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Soundararajan, R.; Naswa, N.; Sharma, P.; Karunanithi, S.; Nazar, A.H.; Das, K.J.; Kumar, R. SPECT-CT for characterization of extraosseous uptake of 99mTc-methylene diphosphonate on bone scintigraphy. Diagn Interv. Radiol. 2013, 19, 405–410. [Google Scholar] [CrossRef] [PubMed]
  2. Wale, D.J.; Wong, K.K.; Savas, H.; Kandathil, A.; Piert, M.; Brown, R.K. Extraosseous findings on bone scintigraphy using fusion SPECT/CT and correlative imaging. Am. J. Roentgenol. 2015, 205, 160–172. [Google Scholar] [CrossRef] [PubMed]
  3. Bermo, M.; Behnia, S.; Fair, J.; Miyaoka, R.S.; Elojeimy, S. Review of Extraskeletal Activity on Tc-99m Methylene Diphosphonate Bone Scintigraphy and Value of Cross-Sectional and SPECT-CT Imaging Correlation. Curr. Probl. Diagn. Radiol. 2018, 47, 324–332. [Google Scholar] [CrossRef] [PubMed]
  4. Zwas, S.T.; Shpilberg, O.; Huszar, M.; Rozenman, J. Isolated ectopic lung uptake of technetium 99m methylene diphosphonate on bone scintigraphy in primary amyloidosis. Eur. J. Pediatr. 1990, 17, 282–285. [Google Scholar] [CrossRef] [PubMed]
  5. Gezici, A.; Van Duijnhoven, E.M.; Bakker, S.J.; A Heidendal, G.; Van Kroonenburgh, M.J. Lung and gastric uptake in bone scintigraphy of sarcoidosis. J. Nucl. Med. 1996, 37, 1530–1532. [Google Scholar] [PubMed]
  6. Cohenpour, M.; Dotan, E.; Kopel, L.; Horne, T. Thoracic Cage Uptake in Bone Scintigraphy Secondary to Lung Abscess With Extrapleural Invasion. Clin. Nucl. Med. 2006, 31, 79–81. [Google Scholar] [CrossRef] [PubMed]
  7. Nursal, G.N.; Reyhan, M.; Yapar, A.F. Focal 99mTc-DMSA uptake in lung parenchyma without structural alterations on SPECT/CT. Clin. Nucl. Med. 2015, 40, e520–e521. [Google Scholar] [CrossRef] [PubMed]
  8. Kou, Y.; Shen, G.; Ou, X.; Huang, R.; Kuang, A. Focal pulmonary uptake on 99mTc-sestamibi parathyroid scintigraphy due to iatrogenic microembolism. Clin. Nucl. Med. 2018, 43, 33–35. [Google Scholar] [CrossRef] [PubMed]
  9. Sharma, A.; Kaushik, P.; Singh, T.P.; Patel, C. Focal pulmonary uptake on myocardial perfusion scintigraphy due to iatrogenic microembolism. J. Nucl. Cardiol. 2018, 26, 2133–2135. [Google Scholar] [CrossRef] [PubMed]
  10. Panagiotidis, E.; Seshadri, N.; Fernando, R.; Healey, P.; Vinjamuri, S. 68Ga-DOTANOC focal pulmonary activity with no corresponding CT abnormality. Clin. Nucl. Med. 2016, 41, 948–950. [Google Scholar] [CrossRef] [PubMed]
  11. Sasikumar, A.; Thampan, S.; Thomas, N.; Paul, R. 68Ga–Prostate-Specific Membrane Antigen Focal Pulmonary Activity With No Corresponding CT Abnormality. Clin. Nucl. Med. 2020, 46, e88–e89. [Google Scholar] [CrossRef] [PubMed]
  12. Chondrogiannis, S.; Marzola, M.C.; Grassetto, G.; Zorzi, A.; Milan, E.; Rampin, L.; Colletti, P.M. 18F-FDG PET/CT lung ‘focalities’ without coregistered CT findings: An interpretative clinical dilemma. Nucl. Med. Commun. 2015, 36, 334–339. [Google Scholar] [CrossRef] [PubMed]
  13. Liu, Y. Lung hot spot without corresponding computed tomography abnormality on fluorodeoxyglucose positron emission tomography/computed tomography: Artifactual or real, iatrogenic or pathologic? Curr. Probl. Diagn Radiol. 2017, 46, 200–203. [Google Scholar] [CrossRef] [PubMed]
  14. Lei, L.; Deng, Y.; Ding, H.; Zhang, W. Iatrogenic lung microembolism resulted in extraosseous uptake of 99mTc-MDP. Clin. Nucl. Med. 2020, 45, 871–872. [Google Scholar] [CrossRef] [PubMed]
  15. Ozdemir, E.; Poyraz, N.Y.; Keskin, M.; Kandemir, Z.; Turkolmez, S. Hot-Clot Artifacts in the Lung Parenchyma on F-18 Fluorodeoxyglucose Positron Emission Tomography/CT due to Faulty Injection Techniques: Two Case Reports. Korean J. Radiol. 2014, 15, 530–533. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Kvaternik, H.; Gatterer, J.; Plhak, E.; Schwarzgruber, J.F.; Aigner, R.M. Systematic assessment of the adsorption of 99mTc-radiopharmaceuticals onto plastic syringes. J. Nucl. Med. Technol. 2020, 48, 168–173. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Eberlé, M.-C.; Fersing, C.; Guillemard, S.; Ilonca, D.; Guiu, S.; Deshayes, E. Unusual Focal Lung Uptake without CT Abnormality on a Bone Scan: What Might It Mean? Diagnostics 2022, 12, 934. https://doi.org/10.3390/diagnostics12040934

AMA Style

Eberlé M-C, Fersing C, Guillemard S, Ilonca D, Guiu S, Deshayes E. Unusual Focal Lung Uptake without CT Abnormality on a Bone Scan: What Might It Mean? Diagnostics. 2022; 12(4):934. https://doi.org/10.3390/diagnostics12040934

Chicago/Turabian Style

Eberlé, Marie-Claude, Cyril Fersing, Sophie Guillemard, Diana Ilonca, Séverine Guiu, and Emmanuel Deshayes. 2022. "Unusual Focal Lung Uptake without CT Abnormality on a Bone Scan: What Might It Mean?" Diagnostics 12, no. 4: 934. https://doi.org/10.3390/diagnostics12040934

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop